Perbedaan Prodia Diagnostic Line Tbk dan Charlie Hospital Semarang Tbk.: Prodia Diagnostic Line Tbk diperdagangkan di Rp270 (kapitalisasi pasar 474,07 M, volume 24 jam 21,23 jt), sedangkan Charlie Hospital Semarang Tbk. diperdagangkan di Rp308 (kapitalisasi pasar 826,8 M, volume 24 jam 22,2 jt). Perbedaan utamanya: Charlie Hospital Semarang Tbk. lebih besar dari sisi kapitalisasi pasar, dan Charlie Hospital Semarang Tbk. lebih aktif diperdagangkan (22,2 jt vs 21,23 jt). Mana yang lebih baik tergantung tujuan investasimu.
| PRDL | RSCH | |
|---|---|---|
Kapitalisasi Pasar | 474,07 M | 826,8 M |
Volume | 21,23 jt | 22,2 jt |
Lot | 212,3 rb | 221,97 rb |
Perputaran | 5,77 M | 6,93 M |
Harga Rata-rata | 271,63 | 312,29 |
Nilai Transaksi | 5,77 M | 6,93 M |
Harga Ekuilibrium Indikatif | 270 | 308 |
Volume Ekuilibrium Indikatif | 2,21 rb | 25 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Selengkapnya di halaman PRDL →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →